Nomura Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-56,564
| Closed | -$5.26M | – | 2657 |
|
|
2021
Q4 | $5.26M | Buy |
+56,564
| New | +$3.73M | 0.01% | 681 |
|
|
2016
Q3 | – | Sell |
-2,102
| Closed | -$36K | – | 1441 |
|
|
2016
Q2 | $36K | Buy |
+2,102
| New | +$37.6K | ﹤0.01% | 1175 |
|
|
2015
Q3 | – | Sell |
-1,525
| Closed | -$73K | – | 2050 |
|
|
2015
Q2 | $73K | Buy |
+1,525
| New | +$66.2K | ﹤0.01% | 1692 |
|
|
2015
Q1 | – | Sell |
-10,687
| Closed | -$394K | – | 2407 |
|
|
2014
Q4 | $394K | Buy |
10,687
+3,187
| +42% | +$129K | ﹤0.01% | 1736 |
|
|
2014
Q3 | $326K | Sell |
7,500
-17,235
| -70% | -$769K | ﹤0.01% | 2119 |
|
|
2014
Q2 | $1.46M | Buy |
24,735
+2,347
| +10% | +$148K | ﹤0.01% | 1284 |
|
|
2014
Q1 | $1.41M | Buy |
22,388
+16
| +0.1% | +$1.06K | ﹤0.01% | 1326 |
|
|
2013
Q4 | $1.3M | Sell |
22,372
-6,360
| -22% | -$332K | 0.01% | 875 |
|
|
2013
Q3 | $1.51M | Buy |
28,732
+24,826
| +636% | +$1.67M | 0.01% | 925 |
|
|
2013
Q2 | $302K | Buy |
+3,906
| New | +$319K | ﹤0.01% | 1601 |
|
Nomura Holdings's ARNA Position: Q1 2022 in Review
Nomura Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 56,564 shares — an estimated $5.26M sold.
Nomura Holdings first reported a position in ARNA in Q2 2013 and held it in 10 quarters. The position peaked at $5.26M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Nomura Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Nomura Holdings sold 56,564 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.26M.
- Nomura Holdings first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
- Nomura Holdings's Arena Pharmaceuticals Inc position peaked at $5.26M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.